Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Three-monthly Dynamic Evaluation of CEA and CA 15.3 vs Usual Practice in the Follow-up of Early Breast Cancer Patients: a Randomized Study

NCT02261389 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT02261389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02261389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Three-monthly Dynamic Evaluation of CEA and CA 15.3 vs Usual Practice in the Follow-up of Early Breast Cancer Patients: a Randomized Study
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 30, 2014
Completion date
December 31, 2030
Enrollment
1,507 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer